Enhancement of tigecycline potency using efflux pump inhibitors
    2.
    发明授权
    Enhancement of tigecycline potency using efflux pump inhibitors 失效
    使用外排泵抑制剂增强替加环素效力

    公开(公告)号:US07879795B2

    公开(公告)日:2011-02-01

    申请号:US11832626

    申请日:2007-08-01

    IPC分类号: A61K38/00

    摘要: Disclosed herein are Efflux Pump Inhibitor (EPI) compounds that can be co-administered with antimicrobial agents for the treatment of infections caused by drug resistant pathogens. The EPI compounds are soft drugs which exhibit a reduced propensity for tissue accumulation. It is demonstrated that the EPIs can be used to increase the potency, decrease bacterial resistance and development of bacterial resistance, and increase killing effectivness of tigecycline. Also disclosed are methods of treatment and pharmaceutical compositions for co-administering tigecylcine with an EPI.

    摘要翻译: 本文公开了可与抗微生物剂共同施用以治疗由耐药性病原体引起的感染的流出泵抑制剂(EPI)化合物。 EPI化合物是表现出组织积累倾向降低的软性药物。 证明EPI可用于增加效力,降低细菌耐药性和细菌耐药性的发展,并增加替加环素的杀伤效果。 还公开了治疗方法和药物组合物,用于与十二烷基苯共同施用EPI。